Sharon L Mulvagh MD
Echocardiography
Professor Emeritus, Cardiovascular Medicine, Mayo Medical School Professor of Medicine, Dalhousie University
Join to View Full Profile
200 1st St SWRochester, MN 55905
Phone+1 902-473-7383
Fax+1 902-473-2434
Dr. Mulvagh is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Baylor College of MedicineFellowship, Cardiovascular Disease, 1986 - 1989
Boston University Medical CenterResidency, Internal Medicine, 1983 - 1985
University of Ottawa Faculty of MedicineClass of 1981
Certifications & Licensure
MN State Medical License 1991 - 2021
IA State Medical License 2008 - 2018
WI State Medical License 1992 - 2017
TX State Medical License 1986 - 1992
National Board of Echocardiography: Adult ComprehensiveEchocardiography
Awards, Honors, & Recognition
- Fellow (FACC) American College of Cardiology
Clinical Trials
- A Study of Stress Echocardiography in Post-Menopausal Women at Risk for Coronary Disease Start of enrollment: 2004 Apr 01
- Effects of Hyperglycemia on Myocardial Perfusion in Humans With and Without Type 2 Diabetes Start of enrollment: 2010 Feb 01
- Regadenoson Real Time Perfusion Imaging Trial-Optison Start of enrollment: 2012 Jul 31
- Join now to see all
Publications & Presentations
PubMed
- Cardiovascular and Kidney Outcomes and Mortality With Long-Acting Injectable and Oral Glucagon-Like Peptide 1 Receptor Agonists in Individuals With Type 2 Diabetes: A ...Matthew M Y Lee, Naveed Sattar, Rodica Pop-Busui, John Deanfield, Scott S Emerson
Diabetes Care. 2025-05-01 - 3 citationsOral Semaglutide and Cardiovascular Outcomes in High-Risk Type 2 Diabetes.Darren K McGuire, Nikolaus Marx, Sharon L Mulvagh, John E Deanfield, Silvio E Inzucchi
The New England Journal of Medicine. 2025-03-29 - 1 citationsOral Semaglutide and Cardiovascular Outcomes in Persons With Type 2 Diabetes, According to SGLT2i Use: Prespecified Analyses of the SOUL Randomized Trial.Nikolaus Marx, John E Deanfield, Johannes F E Mann, Rosario Arechavaleta, Stephen C Bain
Circulation. 2025-03-29
Lectures
- Niche Applications for Echo Contrast2019 ACC Scientific Session & Expo, New Orleans - 3/16/2019
- Optimal Use of Ultrasound-Enhancing Agents (aka Echo Contrast)2019 ACC Scientific Session & Expo, New Orleans - 3/16/2019
- Glucagon-Like Peptide 1 Modulates Reductions in Myocardial Blood Flow Reserve during Euglycemia and Hyperglycemia in Both Type 2 Diabetics and Non-DiabeticsRochester, MN - 6/15/2014
Press Mentions
Understanding Women’s Heart Health | ZTV NewsFebruary 13th, 2023- A Coalition of Women’s Hospitals Is Aiming to Treat the Gap in Women’s HealthJune 10th, 2021
- Science from down Under in the September JASE!September 4th, 2020
- Join now to see all
Grant Support
- Venous Pooling In Abdominopelvic And Peripheral Vasculature In Low Body PressureNational Center For Research Resources1996–1997
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
